nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—ADRB2—polycystic ovary syndrome	0.796	1	CbGaD
Sotalol—Distention—Metformin—polycystic ovary syndrome	0.0112	0.165	CcSEcCtD
Sotalol—Respiratory distress—Metformin—polycystic ovary syndrome	0.00416	0.0611	CcSEcCtD
Sotalol—Heartburn—Metformin—polycystic ovary syndrome	0.00384	0.0564	CcSEcCtD
Sotalol—Lightheadedness—Metformin—polycystic ovary syndrome	0.00237	0.0347	CcSEcCtD
Sotalol—Lethargy—Metformin—polycystic ovary syndrome	0.00196	0.0288	CcSEcCtD
Sotalol—Pain in extremity—Metformin—polycystic ovary syndrome	0.00192	0.0282	CcSEcCtD
Sotalol—Cramp muscle—Metformin—polycystic ovary syndrome	0.00173	0.0254	CcSEcCtD
Sotalol—Orciprenaline—ADRB2—polycystic ovary syndrome	0.00172	0.193	CrCbGaD
Sotalol—Abdominal distension—Metformin—polycystic ovary syndrome	0.00167	0.0245	CcSEcCtD
Sotalol—Influenza—Metformin—polycystic ovary syndrome	0.00166	0.0244	CcSEcCtD
Sotalol—Angina pectoris—Metformin—polycystic ovary syndrome	0.00162	0.0237	CcSEcCtD
Sotalol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00154	0.0226	CcSEcCtD
Sotalol—Drowsiness—Metformin—polycystic ovary syndrome	0.00148	0.0217	CcSEcCtD
Sotalol—Ibuprofen—PLAT—polycystic ovary syndrome	0.00146	0.164	CrCbGaD
Sotalol—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00145	0.0213	CcSEcCtD
Sotalol—Bradycardia—Metformin—polycystic ovary syndrome	0.00135	0.0198	CcSEcCtD
Sotalol—Angiopathy—Metformin—polycystic ovary syndrome	0.0012	0.0177	CcSEcCtD
Sotalol—Isoprenaline—ADRB3—polycystic ovary syndrome	0.00119	0.134	CrCbGaD
Sotalol—Flatulence—Metformin—polycystic ovary syndrome	0.00114	0.0167	CcSEcCtD
Sotalol—Dysgeusia—Metformin—polycystic ovary syndrome	0.00113	0.0166	CcSEcCtD
Sotalol—Muscle spasms—Metformin—polycystic ovary syndrome	0.00111	0.0163	CcSEcCtD
Sotalol—Vision blurred—Metformin—polycystic ovary syndrome	0.00109	0.016	CcSEcCtD
Sotalol—Syncope—Metformin—polycystic ovary syndrome	0.00104	0.0152	CcSEcCtD
Sotalol—Palpitations—Metformin—polycystic ovary syndrome	0.00102	0.015	CcSEcCtD
Sotalol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00102	0.0149	CcSEcCtD
Sotalol—Hypertension—Metformin—polycystic ovary syndrome	0.000998	0.0146	CcSEcCtD
Sotalol—Myalgia—Metformin—polycystic ovary syndrome	0.000984	0.0144	CcSEcCtD
Sotalol—Chest pain—Metformin—polycystic ovary syndrome	0.000984	0.0144	CcSEcCtD
Sotalol—Oedema—Metformin—polycystic ovary syndrome	0.000943	0.0138	CcSEcCtD
Sotalol—Esmolol—ADRB2—polycystic ovary syndrome	0.000939	0.105	CrCbGaD
Sotalol—Infection—Metformin—polycystic ovary syndrome	0.000937	0.0138	CcSEcCtD
Sotalol—Shock—Metformin—polycystic ovary syndrome	0.000928	0.0136	CcSEcCtD
Sotalol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000924	0.0136	CcSEcCtD
Sotalol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000912	0.0134	CcSEcCtD
Sotalol—Hypotension—Metformin—polycystic ovary syndrome	0.000882	0.0129	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00086	0.0126	CcSEcCtD
Sotalol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000847	0.0124	CcSEcCtD
Sotalol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000841	0.0123	CcSEcCtD
Sotalol—Somnolence—Metformin—polycystic ovary syndrome	0.000839	0.0123	CcSEcCtD
Sotalol—Ibuprofen—BCL2—polycystic ovary syndrome	0.000838	0.094	CrCbGaD
Sotalol—Dyspepsia—Metformin—polycystic ovary syndrome	0.000831	0.0122	CcSEcCtD
Sotalol—Decreased appetite—Metformin—polycystic ovary syndrome	0.00082	0.012	CcSEcCtD
Sotalol—Atenolol—ADRB2—polycystic ovary syndrome	0.000819	0.0919	CrCbGaD
Sotalol—Fatigue—Metformin—polycystic ovary syndrome	0.000813	0.0119	CcSEcCtD
Sotalol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000772	0.0113	CcSEcCtD
Sotalol—Abdominal pain—Metformin—polycystic ovary syndrome	0.000746	0.0109	CcSEcCtD
Sotalol—Asthenia—Metformin—polycystic ovary syndrome	0.000677	0.00993	CcSEcCtD
Sotalol—Pruritus—Metformin—polycystic ovary syndrome	0.000668	0.0098	CcSEcCtD
Sotalol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000646	0.00947	CcSEcCtD
Sotalol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000638	0.0716	CrCbGaD
Sotalol—Dizziness—Metformin—polycystic ovary syndrome	0.000624	0.00916	CcSEcCtD
Sotalol—Vomiting—Metformin—polycystic ovary syndrome	0.0006	0.0088	CcSEcCtD
Sotalol—Rash—Metformin—polycystic ovary syndrome	0.000595	0.00873	CcSEcCtD
Sotalol—Dermatitis—Metformin—polycystic ovary syndrome	0.000594	0.00872	CcSEcCtD
Sotalol—Headache—Metformin—polycystic ovary syndrome	0.000591	0.00867	CcSEcCtD
Sotalol—Nausea—Metformin—polycystic ovary syndrome	0.00056	0.00823	CcSEcCtD
Sotalol—Ibuprofen—PPARG—polycystic ovary syndrome	0.000464	0.0521	CrCbGaD
Sotalol—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000453	0.0508	CrCbGaD
Sotalol—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000388	0.0436	CrCbGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000306	0.00242	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000301	0.00238	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000286	0.00226	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000284	0.00224	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00028	0.00221	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000279	0.0022	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000279	0.0022	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000277	0.00219	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000275	0.00217	CbGpPWpGaD
Sotalol—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—polycystic ovary syndrome	0.000273	0.00216	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000273	0.00215	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000273	0.00215	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000269	0.00213	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000268	0.00212	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.000267	0.00211	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000262	0.00207	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000261	0.00206	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000255	0.00201	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000253	0.002	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—DLG4—polycystic ovary syndrome	0.000251	0.00198	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000248	0.00196	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000248	0.00195	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000246	0.00194	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000245	0.00193	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000243	0.00192	CbGpPWpGaD
Sotalol—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000242	0.00191	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000241	0.0019	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00024	0.00189	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000238	0.00188	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000236	0.00186	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000233	0.00184	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000231	0.00182	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000231	0.00182	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000228	0.0018	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000228	0.0018	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000223	0.00176	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000214	0.00169	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000209	0.00165	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000208	0.00165	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000204	0.00161	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000204	0.00161	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0002	0.00158	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000189	0.00149	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000187	0.00147	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000185	0.00146	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000183	0.00144	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00018	0.00142	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000178	0.0014	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000176	0.00139	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000174	0.00137	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000174	0.00137	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000171	0.00135	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000171	0.00135	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00017	0.00134	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000168	0.00132	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000167	0.00132	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000167	0.00132	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000167	0.00132	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000167	0.00132	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000166	0.00131	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000164	0.00129	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000164	0.00129	CbGpPWpGaD
Sotalol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000163	0.00129	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000163	0.00128	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000159	0.00125	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000158	0.00124	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000158	0.00124	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000155	0.00123	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000155	0.00122	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000154	0.00122	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000154	0.00122	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000154	0.00121	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000152	0.0012	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000151	0.00119	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000149	0.00117	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000147	0.00116	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000144	0.00114	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000143	0.00113	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000143	0.00113	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000143	0.00113	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00014	0.0011	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00014	0.0011	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00014	0.0011	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000139	0.0011	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000136	0.00107	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000134	0.00106	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000133	0.00105	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000131	0.00103	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00013	0.00103	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000127	0.00101	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000127	0.001	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000127	0.000999	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000126	0.000998	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000124	0.000978	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000124	0.000976	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000117	0.000925	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000116	0.000915	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000115	0.00091	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000115	0.000908	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000115	0.000905	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000113	0.000895	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000113	0.00089	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000112	0.000888	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000105	0.000833	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000105	0.000827	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000103	0.000814	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000102	0.000809	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000102	0.000801	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000101	0.000799	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.0001	0.000792	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.93e-05	0.000784	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	9.91e-05	0.000782	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	9.81e-05	0.000775	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	9.81e-05	0.000774	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	9.7e-05	0.000766	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	9.59e-05	0.000757	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.58e-05	0.000756	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.4e-05	0.000742	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.37e-05	0.00074	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.22e-05	0.000728	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	9.2e-05	0.000726	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.2e-05	0.000726	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.16e-05	0.000723	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	9.11e-05	0.000719	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.02e-05	0.000712	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	9e-05	0.00071	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.97e-05	0.000708	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.96e-05	0.000707	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	8.91e-05	0.000703	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.9e-05	0.000703	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.8e-05	0.000695	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.77e-05	0.000693	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.71e-05	0.000688	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	8.54e-05	0.000674	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.45e-05	0.000667	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.45e-05	0.000667	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	8.35e-05	0.000659	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.27e-05	0.000653	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.27e-05	0.000653	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.14e-05	0.000643	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.97e-05	0.000629	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.95e-05	0.000628	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.91e-05	0.000624	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.78e-05	0.000614	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.73e-05	0.00061	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.67e-05	0.000606	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.51e-05	0.000593	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.47e-05	0.000589	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.3e-05	0.000577	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	7.28e-05	0.000574	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	7.12e-05	0.000562	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.79e-05	0.000536	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.64e-05	0.000524	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.62e-05	0.000523	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.48e-05	0.000511	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	6.19e-05	0.000488	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	6.06e-05	0.000478	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.05e-05	0.000478	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.01e-05	0.000475	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.92e-05	0.000468	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.88e-05	0.000464	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.82e-05	0.000459	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.69e-05	0.000449	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.66e-05	0.000447	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.53e-05	0.000437	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.51e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.48e-05	0.000433	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.45e-05	0.00043	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.39e-05	0.000426	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	5.38e-05	0.000425	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.33e-05	0.000421	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.26e-05	0.000416	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.26e-05	0.000415	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.15e-05	0.000406	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.09e-05	0.000402	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.08e-05	0.000401	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	5.04e-05	0.000398	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.98e-05	0.000393	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.98e-05	0.000393	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.97e-05	0.000393	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.93e-05	0.000389	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.81e-05	0.00038	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.73e-05	0.000373	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.71e-05	0.000371	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.69e-05	0.00037	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.62e-05	0.000365	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.62e-05	0.000364	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.59e-05	0.000362	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.52e-05	0.000356	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.38e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.32e-05	0.000341	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.28e-05	0.000338	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.22e-05	0.000333	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	4.13e-05	0.000326	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.04e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.92e-05	0.00031	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.86e-05	0.000305	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.84e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	3.82e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.78e-05	0.000298	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.74e-05	0.000295	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.55e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.55e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.48e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.48e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.42e-05	0.00027	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.39e-05	0.000268	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.35e-05	0.000264	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.32e-05	0.000262	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.31e-05	0.000261	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.29e-05	0.00026	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.23e-05	0.000255	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.22e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.13e-05	0.000247	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.11e-05	0.000245	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	3.1e-05	0.000245	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.06e-05	0.000242	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.04e-05	0.00024	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.03e-05	0.000239	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.99e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.94e-05	0.000232	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.92e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.73e-05	0.000215	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.67e-05	0.000211	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.6e-05	0.000205	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.55e-05	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.54e-05	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.49e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.18e-05	0.000172	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.14e-05	0.000169	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.14e-05	0.000169	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.09e-05	0.000165	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.91e-05	0.000151	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.87e-05	0.000147	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.84e-05	0.000145	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.83e-05	0.000144	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.8e-05	0.000142	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.79e-05	0.000141	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.77e-05	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.76e-05	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.73e-05	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.73e-05	0.000136	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.68e-05	0.000132	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.64e-05	0.00013	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.35e-05	0.000107	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.32e-05	0.000104	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.15e-05	9.11e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.13e-05	8.91e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	7.98e-06	6.3e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7.81e-06	6.16e-05	CbGpPWpGaD
